Selected References
- Acs N, et al. 2009. Senna treatment in pregnant women and congenital abnormalities in their offspring- a population-based case-control study. Reproductive Toxicology Jul 28(1):100-104.
- Avery GS, et al. 1972. Lactulose: a review of its therapeutic and pharmacologic properties with particular reference to ammonia metabolism and its mode of action in portal systemic encephalopathy. Drugs 4:7-48.
- Baldwin WF. 1963. Clinical study of senna administration to nursing mothers: assessment of effects on infant bowel habits. Canadian Medical Association Journal 89:566-568.
- Concin N, et al. 2008. Mineral oil paraffins in human body fat and milk. Food and Chemical Toxicology 46(2):544-552.
- Danhof IE. 1982. Pharmacology, toxicology, clinical efficacy, and adverse effects of calcium polycarbophil, an enteral hydrosorptive agent. Pharmacotherapy 2:18-28.
- Friedrich C, et al. 2011. Lack of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel group, multiple dose study in healthy lactating women. Drug Metab Pharmacokinet 26(5):458-464.
- Gattuso JM, Kamm MA. 1994. Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Safety 10:47-65.
- Hagemann TM. 1998. Gastrointestinal medications and breastfeeding. Journal of Human Lactation 14:259-262.
- Rude RK, Singer FR. 1981. Magnesium deficiency and excess. Annual Review of Medicine 323:245-259.
- Schindler AM. 1984. Isolated neonatal hypomagnesaemia associated with maternal overuse of stool softener. Lancet 2:822.
- The WHO Working Group, Bennet PN (ed). 1988. Drugs and Human Lactation. Elsevier, Amsterdam, New York, Oxford, 88-89.
- Trottier M, et al. 2012. Treating constipation during pregnancy. Canadian Family Physician 58:836-838.
- Werthmann MW, Jr., Krees SV. 1973. Quantitative excretion of Senokot in human breast milk. The Medical Annals of the District of Columbia 42(1):4-5.
